URIKA [bioworks]

We work with biopharmaceutical clients to accelerate novel science and improve their probability of success. We explore scientific white spaces for high impact insights, elucidate & validate underlying target biology, predict and demonstrate efficacy and safety, produce data where none exists and anticipate unexpected outcomes. Our team and our collaborators help clients develop model organisms, tissues, organoids and cell lines that are translationally relevant to biopharmaceutical and healthcare research. Focused on discovery and pre-clinical stages of development, we can produce both healthy and disease biology, manipulate the biology to clients’ needs and then apply a portfolio of sequencing, expression, proteomics and other analytical techniques to elucidate biological mechanisms, identify and validate novel targets and demonstrate efficacy and safety. We have access to a vast library of healthy and diseased cell and tissue lines and will partner with clients for the collection and curation of currently unavailable cells of interest. Our ecosystem of collaborating organizations provide access to leading edge bioinformatics, data science, technology and laboratory facilities. As a “science integrator”, we bring together the disciplines and expertise to produce novel biology and approaches at accelerated speed.